KMI

25.95

-0.88%↓

SLB

37.07

+2.86%↑

VLO

169.52

+0.02%↑

BKR

48.65

+0.5%↑

EQT

55.32

+3%↑

KMI

25.95

-0.88%↓

SLB

37.07

+2.86%↑

VLO

169.52

+0.02%↑

BKR

48.65

+0.5%↑

EQT

55.32

+3%↑

KMI

25.95

-0.88%↓

SLB

37.07

+2.86%↑

VLO

169.52

+0.02%↑

BKR

48.65

+0.5%↑

EQT

55.32

+3%↑

KMI

25.95

-0.88%↓

SLB

37.07

+2.86%↑

VLO

169.52

+0.02%↑

BKR

48.65

+0.5%↑

EQT

55.32

+3%↑

KMI

25.95

-0.88%↓

SLB

37.07

+2.86%↑

VLO

169.52

+0.02%↑

BKR

48.65

+0.5%↑

EQT

55.32

+3%↑

Search

Core Laboratories NV

Atvērts

16.31 2.32

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

15.7

Max

16.33

Rekomendācijas

By TipRanks

Rekomendācijas

Pārdot

Prognoze 12 mēnešiem

-24.72% downside

Dividendes

By Dow Jones

Nākamais dividenžu datums

2025. g. 24. nov.

Nākamais Ex dividenžu datums

2025. g. 3. nov.

Core Laboratories NV Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 2. nov. 22:13 UTC

Peļņas

Westpac Raises Dividend Despite 1% Slip in Annual Profit -- Update

2025. g. 2. nov. 21:23 UTC

Peļņas

Westpac Raises Dividend Despite 1% Slip in Annual Profit

2025. g. 2. nov. 23:43 UTC

Tirgus saruna

Gold Falls on Reports of China's Finance Ministry Ending Tax Incentive for Gold Sales -- Market Talk

2025. g. 2. nov. 23:34 UTC

Tirgus saruna

Oil Rises as OPEC+ Signals Output-Increase Pause -- Market Talk

2025. g. 2. nov. 21:00 UTC

Peļņas

Westpac Has Set Tech Overhaul Goals and Will Share Progress, CEO Says>WBC.AU

2025. g. 2. nov. 21:00 UTC

Peļņas

Westpac Is Now Executing on Tech Overhaul, CEO Says>WBC.AU

2025. g. 2. nov. 21:00 UTC

Peļņas

Westpac Has Completed Tech Overhaul's Discovery and Planning Phases, CEO Says >WBC.AU

2025. g. 2. nov. 20:55 UTC

Peļņas

Westpac FY Australia Mortgage Lending Up 5% on Year>WBC.AU

2025. g. 2. nov. 20:55 UTC

Peļņas

Westpac FY Institutional Lending Up 17% on Year>WBC.AU

2025. g. 2. nov. 20:55 UTC

Peļņas

Westpac FY Business Lending Up 15% on Year>WBC.AU

2025. g. 2. nov. 20:46 UTC

Peļņas

Westpac Expects Completion in 2H of FY 2026>WBC.AU

2025. g. 2. nov. 20:46 UTC

Peļņas

Westpac Expects CET1 Capital Ratio to Rise by 20 Basis Points>WBC.AU

2025. g. 2. nov. 20:45 UTC

Peļņas

Westpac: Sale Is at Slight Premium to Expected Gross Loan Value at Completion>WBC.AU

2025. g. 2. nov. 20:44 UTC

Peļņas

Westpac Selling to Consortium Including KKR, Pimco and Pepper Money>WBC.AU

2025. g. 2. nov. 20:43 UTC

Peļņas

Westpac Agrees to Sell A$21.4B Rams Mortgage Portfolio>WBC.AU

2025. g. 2. nov. 20:42 UTC

Peļņas

Westpac FY Impairment Provisions A$4.99B Vs. A$5.10B>WBC.AU

2025. g. 2. nov. 20:41 UTC

Peļņas

Westpac FY Net Profit Ex-Notable Items A$7.0B, Down 2% on Year>WBC.AU

2025. g. 2. nov. 20:40 UTC

Peļņas

Westpac FY Customer Deposits A$723.0B Vs. A$673.6B>WBC.AU

2025. g. 2. nov. 20:39 UTC

Peļņas

Westpac FY Total Loans A$851.85B Vs. A$806.77B>WBC.AU

2025. g. 2. nov. 20:37 UTC

Peļņas

Westpac FY24 Impairment Charges 5 Bps of Loans Vs. 7 Bps in FY25>WBC.AU

2025. g. 2. nov. 20:37 UTC

Peļņas

Westpac FY Operating Expenses A$11.92B Vs. A$10.94B>WBC.AU

2025. g. 2. nov. 20:37 UTC

Peļņas

Westpac FY Non-Interest Income A$3.00B Vs. A$2.835B>WBC.AU

2025. g. 2. nov. 20:36 UTC

Peļņas

Westpac FY Net Interest Income A$19.38B Vs. A$18.75B>WBC.AU

2025. g. 2. nov. 20:35 UTC

Peļņas

Westpac FY CET1 Level 2 Capital Ratio 12.5% Vs. 12.5%>WBC.AU

2025. g. 2. nov. 20:35 UTC

Peļņas

Westpac FY Net Interest Margin 1.94% Vs. 1.95%>WBC.AU

2025. g. 2. nov. 20:35 UTC

Peļņas

Westpac Raises Dividend to A$0.77 Vs. A$0.76 >WBC.AU

2025. g. 2. nov. 20:34 UTC

Peļņas

Westpac FY Rev A$22.38B Vs. A$21.59B >WBC.AU

2025. g. 2. nov. 20:33 UTC

Peļņas

Westpac FY Net A$6.92B Vs. Net A$6.99B >WBC.AU

2025. g. 2. nov. 14:27 UTC

Peļņas

Berkshire Operating Profits Rose 33% in Third Quarter. There Were No Stock Buybacks. -- Barrons.com

2025. g. 2. nov. 14:25 UTC

Peļņas

Warren Buffett Is Leaving Berkshire Hathaway in Great Shape for His Successor After Profit Results -- Barrons.com

Salīdzinājums

Cenas izmaiņa

Core Laboratories NV Prognoze

Cenas mērķis

By TipRanks

-24.72% uz leju

Prognoze 12 mēnešiem

Vidējais 12 USD  -24.72%

Augstākais 12 USD

Zemākais 12 USD

Pamatojoties uz 2 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Core Laboratories NV — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pārdot

2 ratings

0

Pirkt

1

Turēt

1

Pārdot

Finanšu rādītāji

$

help-icon Live chat